Overview

CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders

Status:
Completed
Trial end date:
2019-12-16
Target enrollment:
Participant gender:
Summary
The proposed study will examine the efficacy of doxazosin in the treatment of PTSD and alcohol use disorder or substance use disorders.
Phase:
Phase 2
Details
Lead Sponsor:
Medical University of South Carolina
VA Office of Research and Development
Collaborators:
Medical University of South Carolina
Ralph H. Johnson VA Medical Center
Treatments:
Doxazosin